Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 47 (RPL21P47) is a non-functional, processed genomic sequence sharing similarity to the ribosomal protein L21 gene but does not encode a protein or have known biological or therapeutic roles. Pseudogenes like RPL21P47 are commonly found throughout the genome as remnants of gene duplication or retrotransposition events; they generally lack promoter activity, do not produce functional proteins, and are not relevant as therapeutic targets or biomarkers[4][6]. Information on related functional genes, such as RPL21, should not be conflated with the pseudogene itself. If searching for a functional ribosomal protein target, refer instead to "Ribosomal protein L21" (RPL21), which is a structural component of the 60S ribosomal subunit with roles in protein synthesis and disease[1][3][5][7]. However, RPL21P47 is not functionally equivalent to RPL21, nor is it known to be expressed or to have phenotypic effects.
None (no known mechanism for drugs or biological effectors)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 47 (RPL21P47).